» Articles » PMID: 36292703

/ Promotes Cell Proliferation and Migration Via Upregulating the Expression of in Pan-Cancer

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2022 Oct 27
PMID 36292703
Authors
Affiliations
Soon will be listed here.
Abstract

Various studies have shown that lysine acetyltransferase 2A (), E2F transcription factor 1 (), and ubiquitin conjugating enzyme E2 C () genes regulated the proliferation and migration of tumor cells through regulating the cell cycle. However, there is a lack of in-depth and systematic research on their mechanisms of action. This study analyzed The Cancer Genome Atlas (TCGA) to screen potential candidate genes and the regulation network of and complex in pan-cancer. Quantitative real-time PCR (qRT-PCR) and Western blotting (WB), cell phenotype detection, immunofluorescence co-localization, chromatin immunoprecipitation assay (ChIP), and RNA-Seq techniques were used to explore the functional of a candidate gene, . We found that the expression of these three genes was significantly higher in more than 10 tumor types compared to normal tissue. Moreover, was mainly expressed in tumor cells, which highlighted the impacts of as a specific therapeutic strategy. Moreover, and could promote cell proliferation and the migration of cancer cells by enhancing the expression of . Mechanically, was found to cooperate with and be recruited by to the promoter for elevating the expression of by increasing the acetylation level of H3K9.

Citing Articles

Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma.

Gao P, Liu Q, Luo Z, Pu W Front Microbiol. 2024; 15:1461456.

PMID: 39735192 PMC: 11671487. DOI: 10.3389/fmicb.2024.1461456.


Succinylation modification-mediated upregulation of Sp1 promotes hepatocellular carcinoma cell proliferation.

Han Y, Deng X, Chen H, Chen J, Xu W, Liu L Discov Oncol. 2024; 15(1):660.

PMID: 39548054 PMC: 11568111. DOI: 10.1007/s12672-024-01533-9.


Exploration of a miRNA-mRNA network shared between acute pancreatitis and Epstein-Barr virus infection by integrated bioinformatics analysis.

Wei X, Weng Z, Xu X, Yao J PLoS One. 2024; 19(11):e0311130.

PMID: 39546499 PMC: 11567522. DOI: 10.1371/journal.pone.0311130.


TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis.

Zhu Z, Zhang W, Huo S, Huang T, Cao X, Zhang Y Front Mol Biosci. 2024; 11:1365655.

PMID: 38756529 PMC: 11096532. DOI: 10.3389/fmolb.2024.1365655.


Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields.

Wei P, Zhu A, Cao R, Zheng C Biology (Basel). 2024; 13(3).

PMID: 38534453 PMC: 10968662. DOI: 10.3390/biology13030184.


References
1.
Meier C, Spitschak A, Abshagen K, Gupta S, Mor J, Wolkenhauer O . Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin. J Pathol. 2014; 234(3):351-64. DOI: 10.1002/path.4400. View

2.
Liu P, Chen C, Shu C, Chang H, Lee C, Liou H . UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma. Diagnostics (Basel). 2020; 10(9). PMC: 7555092. DOI: 10.3390/diagnostics10090674. View

3.
Xiao Q, Xiao J, Liu J, Liu J, Shu G, Yin G . Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction. Cell Death Dis. 2022; 13(3):202. PMC: 8891354. DOI: 10.1038/s41419-022-04649-4. View

4.
Engelmann D, Mayoli-Nussle D, Mayrhofer C, Furst K, Alla V, Stoll A . E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B. J Mol Cell Biol. 2013; 5(6):391-403. PMC: 3888194. DOI: 10.1093/jmcb/mjt035. View

5.
Roci I, Watrous J, Lagerborg K, Lafranchi L, Lindqvist A, Jain M . Mapping Metabolic Events in the Cancer Cell Cycle Reveals Arginine Catabolism in the Committed SGM Phase. Cell Rep. 2019; 26(7):1691-1700.e5. PMC: 6663478. DOI: 10.1016/j.celrep.2019.01.059. View